Review

Published on 27 May 2021

Mechanisms of Neoantigen-Targeted Induction of Pyroptosis and Ferroptosis: From Basic Research to Clinical Applications

in Cancer Immunity and Immunotherapy

Jie Yu
Qing Wang
Xiaoyun Zhang
Zhiliang Guo
Xiaodong Cui

Frontiers in Oncology

doi 10.3389/fonc.2021.685377

8,517 views
15 citations

Case Report

Published on 26 May 2021

Nivolumab for Metastatic Urothelial Cancer in a Renal Allograft Recipient With Subsequent Graft Rejection and Treatment Complete Remission: A Case Report

in Cancer Immunity and Immunotherapy

Didi Chen
Xinyi Wu
Congying Xie

Frontiers in Oncology

doi 10.3389/fonc.2021.646322

2,226 views
3 citations

Review

Published on 26 May 2021

Immunotherapy in the Treatment of Urothelial Bladder Cancer: Insights From Single-Cell Analysis

in Cancer Immunity and Immunotherapy

Jingyu Zang
Kaiyan Ye
Yang Fei
Ruiyun Zhang
Haige Chen
Guanglei Zhuang

Frontiers in Oncology

doi 10.3389/fonc.2021.696716

11,614 views
15 citations

Case Report

Published on 25 May 2021

Rectosigmoid-Junction Squamous Cell Carcinoma With pMMR/MSS Achieved a Partial Response Following PD-1 Blockade Combined With Chemotherapy: A Case Report

in Cancer Immunity and Immunotherapy

Yanxin He
Lunqing Wang
Xiao Li
Tongsong Zhang
Tingting Song
Junling Zhang
Yangyang Yu
Shiqing Chen
Haiping Song

Frontiers in Oncology

doi 10.3389/fonc.2021.596342

2,715 views
3 citations

Original Research

Published on 24 May 2021

Intramuscular Expression of Plasmid-Encoded FVII-Fc Immunoconjugate for Tumor Immunotherapy by Targeting Tumoral Blood Vessels and Cells

in Cancer Immunity and Immunotherapy

Liping Ma
Guanru Wang
Sijia Liu
Feng Bi
Ming Liu
Gang Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.638591

2,182 views
3 citations

Systematic Review

Published on 24 May 2021

Assessment of the Clinical Trials Safety Profile of PD-1/PD-L1 Inhibitors Among Patients With Cancer: An Updated Systematic Review and Meta-Analysis

in Cancer Immunity and Immunotherapy

Yuan Tian
Alan Huang
Yue Yang
Qi Dang
Qing Wen
Linlin Wang
Yuping Sun

Frontiers in Oncology

doi 10.3389/fonc.2021.662392

3,601 views
5 citations

Review

Published on 21 May 2021

Organ-Specific Immune-Related Adverse Events for PD-1 Antibodies in Lung Cancer Treatment

in Cancer Immunity and Immunotherapy

Xiaohu Zheng
Haiming Wei

Frontiers in Oncology

doi 10.3389/fonc.2021.628243

3,623 views
1 citation

Case Report

Published on 21 May 2021

Case Report: Transformation From Non-Small Cell Lung Cancer to Small Cell Lung Cancer During Anti-PD-1 Therapy: A Report of Two Cases

in Cancer Immunity and Immunotherapy

Qian Shen
Jingjing Qu
Lingyan Sheng
Qiqi Gao
Jianying Zhou

Frontiers in Oncology

doi 10.3389/fonc.2021.619371

5,979 views
13 citations

Original Research

Published on 20 May 2021

Immune-Related Gene SERPINE1 Is a Novel Biomarker for Diffuse Lower-Grade Gliomas via Large-Scale Analysis

in Cancer Immunity and Immunotherapy

Xiaoming Huang
Fenglin Zhang
Dong He
Xiaoshuai Ji
Jiajia Gao
Wenqing Liu
Yunda Wang
Qian Liu
Tao Xin

Frontiers in Oncology

doi 10.3389/fonc.2021.646060

8,943 views
33 citations

Case Report

Published on 20 May 2021

Durable Response to Immunotherapy With Antiangiogenic Drug in Large-Cell Lung Carcinoma With Multiple Fulminant Postoperative Metastases: A Case Report

in Cancer Immunity and Immunotherapy

Zhilin Luo
Hong Zhang
Yajie Xiao
Rui Wang
Liping Zhang
Chenglu Huang
Yu Cao
Chao Sun
Yongtian Zhao
Hanqing Lin

Frontiers in Oncology

doi 10.3389/fonc.2021.633446

3,104 views
6 citations

Original Research

Published on 20 May 2021

Risk Models for Advanced Melanoma Patients Under Anti-PD-1 Monotherapy—Ad hoc Analyses of Pooled Data From Two Clinical Trials

in Cancer Immunity and Immunotherapy

Xue Bai
Jie Dai
Caili Li
Chuanliang Cui
Lili Mao
Xiaoting Wei
Xinan Sheng
Zhihong Chi
Xieqiao Yan
Bixia Tang

Frontiers in Oncology

doi 10.3389/fonc.2021.639085

2,431 views
8 citations

Original Research

Published on 19 May 2021

Safety of PD-1/PD-L1 Inhibitors Combined With Palliative Radiotherapy and Anti-Angiogenic Therapy in Advanced Hepatocellular Carcinoma

in Cancer Immunity and Immunotherapy

Liting Zhong
Dehua Wu
Weiwei Peng
Hailong Sheng
Yazhi Xiao
Xuebing Zhang
Yuli Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.686621

5,058 views
40 citations

Original Research

Published on 19 May 2021

The Ferroxidase Hephaestin in Lung Cancer: Pathological Significance and Prognostic Value

in Cancer Immunity and Immunotherapy

Paola Zacchi
Beatrice Belmonte
Alessandro Mangogna
Gaia Morello
Letizia Scola
Anna Martorana
Violetta Borelli

Frontiers in Oncology

doi 10.3389/fonc.2021.638856

3,886 views
12 citations

Original Research

Published on 18 May 2021

Bone Marrow Soluble Mediator Signatures of Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms

in Cancer Immunity and Immunotherapy

Juçara Gastaldi Cominal
Maira da Costa Cacemiro
Maria Gabriela Berzoti-Coelho
Illy Enne Gomes Pereira
Fabiani Gai Frantz
Elizabeth Xisto Souto
Dimas Tadeu Covas
Lorena Lobo de Figueiredo-Pontes
Maria Carolina Oliveira
Kelen Cristina Ribeiro Malmegrim

Frontiers in Oncology

doi 10.3389/fonc.2021.665037

4,035 views
14 citations

Original Research

Published on 17 May 2021

Potential Impact of ALKBH5 and YTHDF1 on Tumor Immunity in Colon Adenocarcinoma

in Cancer Immunity and Immunotherapy

Guanyu Yan
Yue An
Boyang Xu
Ningning Wang
Xuren Sun
Mingjun Sun

Frontiers in Oncology

doi 10.3389/fonc.2021.670490

17,829 views
27 citations

Methods

Published on 17 May 2021

Complement C1q (C1qA, C1qB, and C1qC) May Be a Potential Prognostic Factor and an Index of Tumor Microenvironment Remodeling in Osteosarcoma

in Cancer Immunity and Immunotherapy

Long-hao Chen
Jin-Fu Liu
Yan- Lu
Xin-yu He
Chi- Zhang
Hong-hai Zhou

Frontiers in Oncology

doi 10.3389/fonc.2021.642144

14,672 views
60 citations

Navigation group

Articles

Mechanisms of Neoantigen-Targeted Induction of Pyroptosis and Ferroptosis: From Basic Research to Clinical Applications

Nivolumab for Metastatic Urothelial Cancer in a Renal Allograft Recipient With Subsequent Graft Rejection and Treatment Complete Remission: A Case Report

Immunotherapy in the Treatment of Urothelial Bladder Cancer: Insights From Single-Cell Analysis

Rectosigmoid-Junction Squamous Cell Carcinoma With pMMR/MSS Achieved a Partial Response Following PD-1 Blockade Combined With Chemotherapy: A Case Report

Intramuscular Expression of Plasmid-Encoded FVII-Fc Immunoconjugate for Tumor Immunotherapy by Targeting Tumoral Blood Vessels and Cells

Assessment of the Clinical Trials Safety Profile of PD-1/PD-L1 Inhibitors Among Patients With Cancer: An Updated Systematic Review and Meta-Analysis

Organ-Specific Immune-Related Adverse Events for PD-1 Antibodies in Lung Cancer Treatment

Case Report: Transformation From Non-Small Cell Lung Cancer to Small Cell Lung Cancer During Anti-PD-1 Therapy: A Report of Two Cases

Immune-Related Gene SERPINE1 Is a Novel Biomarker for Diffuse Lower-Grade Gliomas via Large-Scale Analysis

Durable Response to Immunotherapy With Antiangiogenic Drug in Large-Cell Lung Carcinoma With Multiple Fulminant Postoperative Metastases: A Case Report

Risk Models for Advanced Melanoma Patients Under Anti-PD-1 Monotherapy—Ad hoc Analyses of Pooled Data From Two Clinical Trials

Safety of PD-1/PD-L1 Inhibitors Combined With Palliative Radiotherapy and Anti-Angiogenic Therapy in Advanced Hepatocellular Carcinoma

The Ferroxidase Hephaestin in Lung Cancer: Pathological Significance and Prognostic Value

Bone Marrow Soluble Mediator Signatures of Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms

Potential Impact of ALKBH5 and YTHDF1 on Tumor Immunity in Colon Adenocarcinoma

Complement C1q (C1qA, C1qB, and C1qC) May Be a Potential Prognostic Factor and an Index of Tumor Microenvironment Remodeling in Osteosarcoma